CARDINAL HEALTH INC CEDEAR EACH 3 REP 1 NPVCC

CARDINAL HEALTH INC CEDEAR EACH 3 REP 1 NPV

50,850.000ARSD
+50.000+0.10%
As of today at 19:57 GMT
ARS
No trades
See on Supercharts

CAH fundamentals

Key facts

Market capitalization‪32.30 T‬ARS
Basic EPS (TTM)1,666.97ARS
Founded1979
Employees (FY)‪48.9 K‬
CEOJason M. Hollar
About

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪32.30 T‬‬
Price to earning ratio (P/E)
30.45x
Price to sales ratio (P/S)
0.18x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
30.45x
Price to sales ratio (P/S)
0.18x
Valuation ratios
‪0.00‬
‪0.10‬
‪0.20‬
‪0.30‬
‪0.40‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪30.00‬
‪60.00‬
‪90.00‬
‪120.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪0.35%‬
‪0.47%‬
‪0.59%‬
‪0.71%‬
‪0.83%‬
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪15.00 T‬‬
‪‪30.00 T‬‬
‪‪45.00 T‬‬
‪‪60.00 T‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪15.00 T‬‬
‪‪30.00 T‬‬
‪‪45.00 T‬‬
‪‪60.00 T‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪15.00 T‬‬
‪‪30.00 T‬‬
‪‪45.00 T‬‬
‪‪60.00 T‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pharmaceutical and Specialty Solutions
Global Medical Products and Distribution
Other
By country
Period: 2024
United States
International

Dividends

Dividend yield, history and sustainability

Dividend summary
24.21%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.79%
Next payment
178.54
Next ex-date
Apr 1, 2025
Dividend history
‪0.55%‬
‪11.55%‬
‪22.55%‬
‪33.55%‬
‪44.55%‬
2020
2021
2022
2023
2024
‪0.00‬
‪80.00‬
‪160.00‬
‪240.00‬
‪320.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−3.00 T‬‬
‪0.00‬
‪‪3.00 T‬‬
‪‪6.00 T‬‬
‪‪9.00 T‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪10.00 T‬‬
‪‪20.00 T‬‬
‪‪30.00 T‬‬
‪‪40.00 T‬‬
Assets
Liabilities